首页|骨髓增殖性肿瘤患者血清金属蛋白酶抑制剂-1、基质金属蛋白酶-9、血管内皮生长因子与骨髓纤维化程度的相关性

骨髓增殖性肿瘤患者血清金属蛋白酶抑制剂-1、基质金属蛋白酶-9、血管内皮生长因子与骨髓纤维化程度的相关性

扫码查看
目的 探讨骨髓增殖性肿瘤(MPN)患者血清血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)及金属蛋白酶抑制剂-1(TIMP-1)与骨髓纤维化(MF)分级的关系。方法 选择90例费城染色体阴性(Ph-)MPN初诊患者为MPN组。根据世界卫生组织(WHO)2016年骨髓纤维化分级标准将MPN患者分为纤维化前期或早期组54例和明显纤维化期组36例;另选取健康志愿者50例作为对照组。采用酶联免疫吸附实验检测血清VEGF、MMP-9、TIMP-1水平并计算TIMP-1与MMP-9比值(TIMP-1/MMP-9)。采用Spearman秩相关检验分析VEGF、MMP-9、TIMP-1、TIMP-1/MMP-9与MF分级的相关性。绘制受试者工作特征(ROC)曲线分析各指标单独或联合诊断MPN或区分MF分级的预测价值。结果 与对照组相比,MPN组血清VEGF、MMP-9 和 TIMP-1 均升高,差异有统计学意义(P<0,05)。VEGF、MMP-9、TIMP-1、TIMP-1/MMP-9 诊断 MPN 的曲线下面积(AUC)分别为 0。834、0。745、0。923、0。618;VEGF、MMP-9 和 TIMP-1 联合诊断 MPN 的AUC为 0。960;当最佳截断值为0。627时,敏感度为85。56%,特异度为92。00%。与纤维化前期或早期组相比,明显纤维化期组患者血清VEGF、TIMP-1、TIMP-1/MMP-9均升高,差异有统计学意义(P<0。05)。Spearman相关性分析结果显示,VEGF(r=0。378,P=0。001)、TIMP-1(r=0。512,P<0。001)、TIMP-1/MMP-9(r=0。353,P=0。001)与 MPN 患者 MF 分级呈正相关(P<0。05)。ROC 曲线分析显示,VEGF、MMP-9、TIMP-1、TIMP-1/MMP-9区分纤维化前期或早期患者和明显纤维化期患者的AUC分别为0。723、0。523、0。802、0。708;VEGF、TIMP-1和TIMP-1/MMP-9联合区分纤维化前期或早期患者和明显纤维化期患者的AUC为0。838;当最佳截断值为0。530时,敏感度为72。22%,特异度为85。19%。结论 血清VEGF、TIMP-1和TIMP-1/MMP-9均可反映MPN患者MF进展,各指标联合检测可预测MPN患者MF程度。
Correlations of serum tissue inhibitor of metalloproteinases-1,matrix metalloproteinase-9 and vascular endothelial growth factor with degree of myelofibrosis in patients with myeloproliferative neoplasms
Objective To explore the correlations of serum vascular endothelial growth factor(VEGF),matrix metalloproteinase-9(MMP-9)and tissue inhibitor of metalloproteinases-1(TIMP-1)with grading of myelofibrosis(MF)in patients with myeloproliferative neoplasms(MPN).Methods Ninety patients with Philadelphia chromosome negative(Ph-)MPN were selected as MPN group.According to the grading criteria for myelofibrosis by the World Health Organization(WHO)in 2016,MPN pa-tients were divided into pre-fibrosis or early fibrosis group with 54 cases and significant fibrosis group with 36 cases;another 50 healthy volunteers were selected as the control group.Levels of serum VEGF,MMP-9 and TIMP-1 were detected by enzyme-linked immunosorbent assay,and the ratio of TIMP-1 to MMP-9(TIMP-1/MMP-9)was calculated.Spearman rank correlation test was used to analyze the correlations of VEGF,MMP-9,TIMP-1 and TIMP-1/MMP-9 with MF grading.Receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of each indicator a-lone or their combination for diagnosing MPN or distinguishing MF grading.Results Compared with the control group,the serum levels of VEGF,MMP-9 and TIMP-1 in the MPN group increased significantly(P<0.05).Values of area under the curve(AUC)of VEGF,MMP-9,TIMP-1 and TIMP-1/MMP-9 for diagnosing MPN were 0,834,0.745,0.923 and 0.618 respectively;the AUC of the combined diagnosis of MPN by VEGF,MMP-9 and TIMP-1 was 0.960;when the optimal cut-off value was 0.627,the sensitivity was 85.56%,and the specificity was 92.00%.Compared with the pre-fibrosis or early fibrosis group,the serum levels of VEGF,TIMP-1 and TIMP-1/MMP-9 in the significant fibrosis group increased significantly(P<0.05).Spearman correlation analysis showed that VEGF(r=0.378,P=0.001),TIMP-1(r=0.512,P<0.001)and TIMP-1/MMP-9(r=0.353,P=0.001)were positively correlated with the MF grading of MPN patients(P<0.05).ROC curve analysis showed that the values of AUC of VEGF,MMP-9,TIMP-1 and TIMP-1/MMP-9 for distinguishing patients with pre-fibrosis or early fibrosis from those with significant fibrosis were 0.723,0.523,0.802 and 0.708 respectively;the AUC of the combined detection of VEGF,TIMP-1 and TIMP-1/MMP-9 for distinguishing patients with pre-fibrosis or early fibrosis from those with significant fibrosis was 0.838;when the optimal cut-off value was 0.530,the sensitivity was 72.22%,and the specificity was 85.19%.Conclusion Serum VEGF,TIMP-1 and TIMP-1/MMP-9 can reflect the MF progression of MPN patients,and the combined detection of these indica-tors can predict the MF degree of MPN patients.

myeloproliferative neoplasmsmyelofibrosisvascular endothelial growth factormatrix metalloproteinase-9tissue inhibitor of metalloproteinases-1extracellular matrixcollagen deposition

孙玲、李弹弹、吴希锋、门丽杰、贾梅艳、鹿军

展开 >

山东省济南市人民医院血液科,山东济南,271199

骨髓增殖性肿瘤 骨髓纤维化 血管内皮生长因子 基质金属蛋白酶-9 金属蛋白酶抑制剂-1 细胞外基质 胶原沉积

山东省卫健委课题项目

2021M0227

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(11)